Inovio Pharmaceuticals
INO
#8846
Rank
ยฃ0.11 B
Marketcap
ยฃ1.62
Share price
-2.89%
Change (1 day)
13.72%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ7.42 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is ยฃ7.42 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ9.45 M-60.13%
2023-12-31ยฃ23.71 M-10.56%
2022-12-31ยฃ26.51 M8.37%
2021-12-31ยฃ24.46 M-14.6%
2020-12-31ยฃ28.64 M-62.25%
2019-12-31ยฃ75.88 M
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31ยฃ7.48 M-9.39%
2008-12-31ยฃ8.26 M
2003-12-31ยฃ0.18 M1338.03%
2002-12-31ยฃ0.01 M-61.21%
2001-12-31ยฃ0.03 M
2001-03-31ยฃ0.08 M11.74%
2000-03-31ยฃ0.07 M19.96%
1999-03-31ยฃ0.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
ยฃ45.09 B 607,153.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ33.93 B 456,926.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ0.27 B 3,555.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ23.73 B 319,474.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ30.66 B 412,805.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ17.68 B 238,038.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
ยฃ18.48 B 248,807.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA